NEXUSPHARMA Trademark

Trademark Overview

On Friday, January 17, 2020, a trademark application was filed for NEXUSPHARMA with the United States Patent and Trademark Office. The USPTO has given the NEXUSPHARMA trademark a serial number of 88764237. The federal status of this trademark filing is REGISTERED as of Tuesday, November 9, 2021. This trademark is owned by Genesisnexuspharma LLC. The NEXUSPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services for others, namely, designing, planning and implementing preclinical phase II trials in mice for patients suffering from cancer by utlizing patient-derived xenograft mouse models to test the efficacy of cancer drugs in treating cancer patients
nexuspharma

General Information

Serial Number88764237
Word MarkNEXUSPHARMA
Filing DateFriday, January 17, 2020
Status700 - REGISTERED
Status DateTuesday, November 9, 2021
Registration Number6555931
Registration DateTuesday, November 9, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2020

Trademark Statements

Goods and ServicesConsulting services for others, namely, designing, planning and implementing preclinical phase II trials in mice for patients suffering from cancer by utlizing patient-derived xenograft mouse models to test the efficacy of cancer drugs in treating cancer patients

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 23, 2020
Primary Code042
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

Trademark Owner History

Party NameGenesisnexuspharma LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesisnexuspharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesisnexuspharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Wednesday, September 27, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 9, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, October 7, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 6, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 31, 2021USE AMENDMENT FILED
Monday, September 13, 2021SOU EXTENSION 1 GRANTED
Monday, July 26, 2021SOU EXTENSION 1 FILED
Monday, September 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 31, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 31, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, August 31, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, August 31, 2021PETITION TO REVIVE-GRANTED
Tuesday, August 31, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, August 30, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 30, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 1, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 6, 2020NON-FINAL ACTION E-MAILED
Monday, April 6, 2020NON-FINAL ACTION WRITTEN
Monday, April 6, 2020ASSIGNED TO EXAMINER
Thursday, January 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 21, 2020NEW APPLICATION ENTERED

Related Keywords

nexuspharma cancer patients derived patient utlizing xenograft mouse drugs treating efficacy